Clinical Vignette
Patient: "Mrs. G," 74-year-old retired teacher, brought by her daughter for evaluation after neighbors reported that Mrs. G has been talking to people who are not there and accusing the mail carrier of stealing her social security checks.
Chief Complaint (daughter): "Mom has been acting paranoid for about 3 months. She insists someone is coming into her apartment at night and moving her things around."
History of Present Illness: Mrs. G's daughter reports a gradual onset over 3 months of persecutory delusions (belief that the mail carrier steals her checks, neighbors spy on her through the walls), visual hallucinations (sees "a man standing in the corner" of her bedroom at night), and auditory hallucinations (hears voices commenting on her activities). Mrs. G's daily functioning has declined: she has stopped cooking for herself ("The food is being poisoned"), has lost 8 pounds in 2 months, and has become increasingly socially withdrawn. Her daughter notes that Mrs. G's memory has been "getting worse" over the past year: she repeats questions within the same conversation, forgets recent phone calls, and recently got lost driving to a grocery store she has patronized for 20 years.
Cognitive Assessment: MoCA score: 18/30 (significant impairment). Deficits in short-term recall (0/5 delayed recall), visuospatial function (clock drawing errors), and executive function (Trail Making B errors). Language and naming intact.
Psychiatric History: No prior psychiatric history. No previous psychotic symptoms, depression, or mania. Personality described as "warm, sociable, and trusting" by daughter.
Medical History: Hypertension (losartan 50mg), type 2 diabetes (metformin 1000mg), hypothyroidism (levothyroxine 75mcg), chronic insomnia (intermittent diphenhydramine use).
Laboratory Results: TSH: 4.2 mIU/L (normal range). Vitamin B12: 280 pg/mL (low-normal). RPR: nonreactive. CBC, CMP: within normal limits. Urinalysis: negative for infection.
Brain MRI: Generalized cortical atrophy with prominent hippocampal volume loss. No acute infarcts. Moderate periventricular white matter changes.
Step 1: Hierarchical Exclusion
In geriatric psychiatry, new-onset psychosis after age 60 mandates a systematic exclusion of organic etiologies before considering primary psychiatric disorders. The hierarchy:
Priority 1: Delirium (Medical Emergency)
Onset: Acute (hours to days), fluctuating. Mrs. G's onset is gradual (3 months), progressive, and relatively stable. Against delirium.
Attention: Delirium impairs attention prominently. Mrs. G's attention was assessable during MoCA (able to complete serial 7s with some errors). Against delirium.
Precipitant: Diphenhydramine (anticholinergic) could cause delirium, but the 3-month chronic course is inconsistent with an acute anticholinergic delirium. However: Chronic anticholinergic use in the elderly contributes to cognitive decline and should be discontinued regardless.
Labs/UA: No UTI, metabolic derangement, or acute illness identified. Delirium ruled out as primary diagnosis.
Priority 2: Neurocognitive Disorder (Major) with Behavioral Disturbance
Cognitive decline: 1-year history of progressive memory impairment (repeating questions, forgetting calls, getting lost in familiar places). MoCA 18/30 with deficits in recall, visuospatial, and executive function.
Functional decline: Stopped cooking, weight loss, social withdrawal. These represent a decline from prior level of functioning confirmed by family.
Neuroimaging: Hippocampal atrophy and generalized cortical atrophy are consistent with Alzheimer's disease.
Psychosis: Visual hallucinations, persecutory delusions, and auditory hallucinations are common behavioral/psychological symptoms of dementia (BPSD). A substantial proportion of patients with Alzheimer's disease develop psychotic symptoms during the course of illness.
Assessment: Strong fit. The cognitive decline preceded the psychosis, the neuroimaging is consistent with neurodegenerative disease, and the psychotic content (theft, persecution) is typical of dementia-associated psychosis.
Priority 3: Late-Onset Schizophrenia Spectrum Disorder
Against: No prior psychiatric history. Premorbid personality was warm and sociable (opposite of schizoid prodrome). Cognitive deficits are progressive and multimodal (memory, visuospatial, executive), which is characteristic of neurodegeneration rather than schizophrenia. Late-onset schizophrenia typically preserves cognition in the early phase. Visual hallucinations are more common in neurocognitive disorders; auditory hallucinations are more common in schizophrenia, but both can occur in either condition.
Assessment: Poor fit. The progressive cognitive decline and neuroimaging findings point to a neurodegenerative process as the primary etiology.
Priority 4: Major Depressive Disorder with Psychotic Features
Against: No prominent depressed mood, anhedonia, or guilt. The social withdrawal and weight loss are better explained by the dementia and paranoid beliefs than by depression. However: Depression is common comorbidity in dementia and should be monitored.
Priority 5: Medication-Induced Psychosis
Current medications (losartan, metformin, levothyroxine) are not associated with psychosis. However: Diphenhydramine (anticholinergic) can worsen cognitive function and contribute to confusion/hallucinations in the elderly. This is a contributing factor rather than the primary cause.
Diagnostic Formulation
Primary Diagnosis
Major Neurocognitive Disorder due to Probable Alzheimer's Disease, with Behavioral Disturbance (Psychosis) (F02.81 + G30.9)
Supporting evidence: progressive cognitive decline over 1+ year, MoCA 18/30 with multi-domain deficits, hippocampal atrophy on MRI, psychotic symptoms (delusions and hallucinations) consistent with BPSD, no prior psychiatric history, no evidence of primary psychiatric disorder.
Contributing Factor
Chronic diphenhydramine use likely exacerbates cognitive impairment and may potentiate psychotic symptoms. Discontinuation recommended with sleep hygiene counseling as alternative.
Teaching Points
- New-onset psychosis after age 60 should always prompt evaluation for neurocognitive disorder, delirium, and medical/medication causes before considering primary psychiatric diagnoses. The base rate of dementia-associated psychosis far exceeds late-onset schizophrenia in this age group.
- Visual hallucinations are a red flag for organic etiology (neurocognitive disorder, delirium, Lewy body disease). Primary psychiatric disorders more commonly produce auditory hallucinations.
- The Beers Criteria list diphenhydramine as "potentially inappropriate" for geriatric patients due to anticholinergic burden. Chronic anticholinergic use in the elderly is associated with increased dementia risk and should be avoided.
- MoCA (Montreal Cognitive Assessment) is preferred over MMSE for detecting early cognitive impairment because it is more sensitive to executive dysfunction and visuospatial deficits, which are commonly affected early in Alzheimer's disease.
- Psychotic symptoms in dementia respond poorly to typical antipsychotics and carry a FDA Black Box Warning for increased mortality in elderly patients with dementia-related psychosis. Pimavanserin (Nuplazid) is the only FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease dementia; for Alzheimer's-related psychosis, brexpiprazole (Rexulti) received FDA approval in 2023.
- The temporal relationship between cognitive decline and psychosis onset is diagnostically important. In neurocognitive disorders, cognitive decline precedes or co-occurs with psychosis. In late-onset schizophrenia, psychosis typically precedes any cognitive decline.